Hostname: page-component-84b7d79bbc-rnpqb Total loading time: 0 Render date: 2024-07-27T17:33:41.263Z Has data issue: false hasContentIssue false
  • English
  • Français

Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years

Published online by Cambridge University Press:  02 January 2015

Jorge G. Paez ,
Anna S. Levin ,
Mariusa Basso ,
Laura B. Gomez ,
Satiko Gobara ,
Fernanda Spadão ,
Isabel Oshiro  and
Silvia Figueiredo Costa
Jorge G. Paez
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Anna S. Levin
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Mariusa Basso
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Laura B. Gomez
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Satiko Gobara
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Fernanda Spadão
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Isabel Oshiro
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
Silvia Figueiredo Costa*
Affiliation:
Department of Infectious Diseases, University of São Paulo Medical School, São Paulo, SP, Brazil
*
Department of Infectious Diseases, Hospital das Clinicas of University of São Paulo, Av. Enéas de Carvalho Aguiar, n° 500-2°, Andar LIM54, CEP:05410-000, São Paulo, Brazil (costasilviaf@ig.com.br)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 10 , October 2008 , pp. 989 - 990
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

References

1.Sanyal, SC, Mokaddas, EM. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 1999;11:28–33.Google Scholar
2.Del Toro, MD, Rodriguez-Baño, J, Herrero, M, et al.Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection. Medicine 2002;81:228–239.Google Scholar
3.Carmeli, Y, Samore, H. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 1997;24:1131–1134.Google Scholar
4.Meyer, E, Schwab, F, Gastmeier, P, Rüden, H, Daschner, FD. Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units? Eur J Clin Microbiol Infect Dis 2006;25:711–714Google Scholar
5.Jones, RN, Sader, HS, Beach, ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18,569 strains of non-fermentative gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001). Int J Antimicrob Agents 2003;22:551–556.Google Scholar
6.World Health Organization Collaborating Center For Drug Statistic Methodology. Anatomical Therapeutic Chemical (ATC) classification index with defined daily dose (DDD). 2008. Available at: http://www.whocc.no/atcddd/.Google Scholar
7.Krcmery, V Jr, Sykora, P, Trupl, J, et al.Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer center. J Chemother 2001;13:133–142.Google Scholar
8.Metan, G, Hayran, M, Hascelik, G, Uzun, O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 2006;38:527–531.Google Scholar